Growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line

被引:0
|
作者
Hong Li
机构
基金
中国国家自然科学基金;
关键词
Colonic adenocarcinoma; Wild-type Kras2; Cell cycle; Apoptosis;
D O I
暂无
中图分类号
R735.35 [];
学科分类号
100214 ;
摘要
AIM: To observe the growth inhibitory effect of wild-type Kras2 gene on a colonic adenocarcinoma cell line Caco-2. METHODS: Recombinant plasmid pCI-neo-Kras2 with wild type Kras2 open reading frame was constructed. The Caco-2 cells were transfected with either pCI-neo or pCI-neo-Kras2 using Lipofectamine 2000. The expression of wild type Kras 2 was examined by Northern blot analysis. And the expression of wild type Kras2 protein was examined by Western blot analysis. The effects of wild-type Kras2 on cell proliferation were analyzed by monotetrazolium (MTT) assay, meanwhile analyses of cell cycle and spontaneous apoptosis rate were carried out by flow cytometry (FCM). RESULTS: The plasmid of pCI-neo-Kras 2 was successfully established. The growth rate of cells transfected with pCI-neo-Kras2 was significantly lower than the control cells transfected with the empty pCI-neo vector (P < 0.05). Cell cycle analysis revealed arrest of the pCI-neo-Kras2 transfected cells in G0/G1 phases, decreased DNA synthesis and decreased fractions of cells in S phase. The proliferative index of cells transfected with pCI-neo-Kras2 was decreased compared with the control cells (49.78% vs 64.21%),while the apoptotic rate of Caco-2 cells with stable Kras 2 expression increased (0.30% vs 0.02%). CONCLUSION: The wild-type Kras2 gene effectively inhibits the growth of the colonic adenocarcinoma cell line Caco-2.
引用
收藏
页码:934 / 938
页数:5
相关论文
共 50 条
  • [41] GROWTH INHIBITORY ACTIVITY OF HUMAN COLONIC ADENOCARCINOMA CELL-LINES INVITRO
    FIENNES, AGTW
    GRANT, AG
    WINTERBOURNE, DA
    HERMONTAYLOR, J
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1748 - 1749
  • [42] REQUIREMENTS FOR GROWTH AND DIFFERENTIATION OF A HUMAN COLONIC ADENOCARCINOMA CELL-LINE
    ROGNONI, JB
    LEHMANN, M
    ROCCABIANCA, M
    DANG, J
    GIANELLINI, F
    MARVALDI, J
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 1994, 30A (08) : 483 - 484
  • [43] Wild-type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma
    Masuishi, Yusuke
    Arakawa, Noriaki
    Kawasaki, Hiroshi
    Miyagi, Etsuko
    Hirahara, Fumiki
    Hirano, Hisashi
    FEBS JOURNAL, 2011, 278 (09) : 1470 - 1483
  • [44] Therapeutic effect of biweekly cetuximab combined with first-line chemotherapy on KRAS/RAS wild-type advanced colorectal cancer
    Li, Jing
    Li, Jianjiong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (10): : 12348 - 12355
  • [45] Identification of Transcriptional Subgroups in EGFR-Mutated and EGFR/KRAS Wild-Type Lung Adenocarcinoma Reveals Gene Signatures Associated with Patient Outcome
    Planck, Maria
    Isaksson, Sofi
    Veerla, Srinivas
    Staaf, Johan
    CLINICAL CANCER RESEARCH, 2013, 19 (18) : 5116 - 5126
  • [46] Stable growth of wild-type hepatitis A virus in cell culture
    Konduru, K
    Kaplan, GG
    JOURNAL OF VIROLOGY, 2006, 80 (03) : 1352 - 1360
  • [47] Adenocarcinoma arising from intracranial recurrent mature teratoma and featuring mutated KRAS and wild-type BRAF genes
    Kim, Eun Soo
    Kwon, Mi Jung
    Song, Joon Ho
    Kim, Dong Hoon
    Park, Hye-Rim
    NEUROPATHOLOGY, 2015, 35 (01) : 44 - 49
  • [48] Profile of panitumumab as first-line treatment in patients with wild-type KRAS metastatic colorectal cancer
    Patel, Shiven B.
    Gill, David
    Garrido-Laguna, Ignacio
    ONCOTARGETS AND THERAPY, 2016, 9 : 75 - 86
  • [49] Inhibitory effect of acidic pH on OmpC porin: wild-type and mutant studies
    Liu, NZ
    Delcour, AH
    FEBS LETTERS, 1998, 434 (1-2) : 160 - 164
  • [50] Decreased expression of DAB2IP in pancreatic cancer with wild-type KRAS
    Duan, Yifan
    Li, Zijun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 356 - 356